LivaNova PLC (LIVN) stock
LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3021% above fair value
$94.54+2.62 (+2.85%)
Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –
LivaNova operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
LivaNova's operating cash flow for the twelve months ending Jun 30, 2026 was $249.26M, up 15.1% year over year. For fiscal 2025 it was $254.34M, up 39.0% from the year before. Over ten years it grew 16.7% a year on average. The highest annual figure on record is $254.34M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $254.34M | +39.0% |
| FY2024 | Dec 31, 2024 | $183.04M | +144.3% |
| FY2023 | Dec 31, 2023 | $74.91M | +7.1% |
| FY2022 | Dec 31, 2022 | $69.92M | -31.8% |
| FY2021 | Dec 31, 2021 | $102.54M | – |
| FY2020 | Dec 31, 2020 | -$79.42M | – |
| FY2019 | Dec 31, 2019 | -$91.14M | -175.6% |
| FY2018 | Dec 31, 2018 | $120.49M | +31.9% |
| FY2017 | Dec 31, 2017 | $91.34M | +14.6% |
| FY2015 | Apr 24, 2015 | $79.68M | +47.0% |
| FY2014 | Apr 25, 2014 | $54.20M | -31.4% |
| FY2013 | Apr 26, 2013 | $79.05M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $66.59M | +5.8% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $15.22M | -36.5% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $82.40M | +4.7% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $85.06M | +66.8% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $62.92M | +45.1% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $23.97M | +140.1% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $78.71M | +45.9% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $50.99M | +181.2% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $43.36M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $9.98M | -51.9% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $53.96M | +188.5% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $18.14M | -49.1% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$17.94M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $20.76M | -19.6% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $18.70M | -44.1% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $35.64M | +48.8% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$10.24M | -140.0% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $25.82M | +32.6% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $33.48M | -9.5% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $23.95M | +176.7% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $25.63M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $19.48M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $36.99M | +1190.5% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $8.66M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$19.02M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$106.05M | -5472.1% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $2.87M | -86.3% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$76.59M | -250.0% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$19.40M | -168.9% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $1.97M | -90.3% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $20.89M | +18.2% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $51.06M | +21.3% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $28.14M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $20.39M | -38.6% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $17.67M | +9.3% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $42.11M | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | -$1.65M | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $33.21M | – |
| Q4 FY2015CQ1 2015 | Apr 24, 2015 | $16.17M | – |
See a number that looks wrong?